As it is, infant formula is very difficult to manufacture and to keep compliant with FDA standards. The industry recognized the implications of the shutdown of the Abbott Nutrition plant and yet the FDA and the White House failed to connect on the issue.
Baby Formula Blues: The Latest Regulatory Fiasco Reveals Problems Bigger Than The Recall Itself
